Start with once-daily ANORO. Once-daily ANORO is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD), including: chronic bronchitis; emphysema; the two conditions together ; Patients studied had moderate or worse COPD. ANORO contains 2 medicines that work together for better breathing and to reduce the number of ...

ANORO should be administered as 1 inhalation once daily, at the same time every day; Do not use ANORO more than 1 time every 24 hours; Contents: 2 blister strips with 30 blisters each. 1 contains umeclidinium: 62.5 mcg/blister* 1 contains vilanterol: 25 mcg/blister* Each inhaler contains 60 blisters and provides 30 doses for a 30-day supply

Please see full Prescribing information, including Patient Information, for ANORO available at ANORO.com

Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive pulmonary disease (COPD). Includes Anoro side effects, interactions and indications.

Learn about ANORO ELLIPTA (umeclidinium & vilanterol inhalation powder), a LAMA/LABA combination therapy for patients with chronic obstructive pulmonary disease (COPD). Find information for healthcare professionals about ANORO ELLIPTA, a prescription medicine.

The recommended dosage of ANORO ELLIPTA for maintenance treatment of COPD is 62.5 mcg umeclidinium and 25 mcg vilanterol (1 actuation of ANORO ELLIPTA 62.5/25 mcg) once daily by oral inhalation. ANORO ELLIPTA should be used at the same time every day.

ANORO ELLIPTA is not used to relieve sudden breathing problems and will not replace a rescue inhaler. • ANORO ELLIPTA is a prescription medicine used long term (chronic) to treat people with chronic obstructive pulmonary disease (COPD). COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both. •

Anoro Ellipta (umeclidinium and vilanterol) is an inhalation powder for chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Side effects of Anoro Ellipta include sore throat, sinus infection, lower respiratory infection, and others.

Mar 18, 2024 · Keep reading for specific information about the dosage of Anoro Ellipta, including its strength and how to take the medication. For a comprehensive look at Anoro Ellipta, see this article.

PrANORO ELLIPTA (umeclidinium/vilanterol) Page 4 of 38 PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS ANORO ELLIPTA (umeclidinium/vilanterol) is a combination of a long-acting muscarinic antagonist (LAMA) and a long-acting beta 2-agonist (LABA) indicated for the long-term once-daily maintenance